# Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife®

> **NCT03545269** · PHASE2 · COMPLETED · sponsor: **Biosolution Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Articular Cartilage Lesion of the Knee

## Interventions

- **DRUG:** CartiLife®
- **PROCEDURE:** Microfracture

## Key facts

- **NCT ID:** NCT03545269
- **Lead sponsor:** Biosolution Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-03
- **Primary completion:** 2017-02-23
- **Final completion:** 2017-02-23
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-06-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03545269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03545269, "Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife®". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03545269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*